Sold 246 shares
of Common Stock
at $7.8325 per share
(Direct)
Date: 2025-06-06 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 21,487.00 | transaction_form_type: 4 | Footnotes: F1
Sold 248 shares
of Common Stock
at $12.1 per share
(Direct)
Date: 2025-09-06 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 21,239.00 | transaction_form_type: 4 | Footnotes: F1
Holds 0 shares
of Common Stock
(Direct)
Date: 2025-06-06 |
Code: H
| nature_of_ownership: By spouse | shares_owned_after: 40.00
Footnotes:
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
REMARKS: Share amount and share prices reflect a 1-for-25 reverse stock split effective on June 16, 2025.
🔍 Wettig Thane (Executive)
Company: FIBROGEN INC (FGEN)
Report Date: 2025-06-06
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-06-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 21,487.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-09-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 21,239.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2025-06-06 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 40.00
Footnotes: